Nektar Therapeutics reported $29.47M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
ALKERMES ALKS:US 136.21M 2.97M
Amgen AMGN:US $ 1.31B 79M
Astrazeneca AZN:US 2.99B 412M
Baxter International BAX:US $ 630M 18M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Biogen BIIB:US $ 654.1M 16.8M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Cara Therapeutics CARA:US $ 5.88M 262K
Dr.Reddys Laboratories DRRD:IN 24B 748M
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Exelixis EXEL:US $ 101.56M 3.06M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Immunogen IMGN:US $ 10.3M 569K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Ironwood Pharmaceuticals IRWD:US $ 27.74M 690K
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Macrogenics MGNX:US $ 17.16M 1.93M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Takeda 4502:JP 212.01B 7.83B
Teva Pharmaceutical TEVA:IT 864M 32M
Xencor XNCR:US $ 10.37M 1.51M
YTE INCY:US $ 190.7M 21.84M